@article{Gangaraju_Manjappa_Subbaiah_Kempaiah_Shinde_Sannaningaiah_2015, title={ANTICOAGULANT AND ANTIPLATELET ACTIVITIES OF JACKFRUIT (ARTOCARPUS HETEROPHYLLUS) SEED EXTRACT}, volume={7}, url={https://journals.innovareacademics.in/index.php/ijpps/article/view/7829}, abstractNote={<div id="__if72ru4sdfsdfrkjahiuyi_once" style="display: none;"> </div><div id="__if72ru4sdfsdfruh7fewui_once" style="display: none;"> </div><div id="__zsc_once"><p><strong>Objective: </strong>The current study focuses on the anticoagulant and antiplatelet activities of aqueous seed extract of Jackfruit (AqSEJ).<strong></strong></p><p><strong>Methods: </strong>Anticoagulant effect of AqSEJ was tested using plasma recalcification time, mouse tail bleeding time, Activated Partial Thromboplastin Time (APTT) and Prothrombin Time (PT). Antiplatelet activity was examined by platelet aggregation studies using agonists such as ADP, Collagen and Epinephrine.<strong></strong></p><p><strong>Results: </strong>The AqSEJ enhanced the clotting time of citrated human plasma from control 200±10 s to 740±14 s. The anticoagulant activity of AqSEJ was further strengthened by <em>in-vivo</em> mouse tail bleeding assay. The <em>i. v.</em> injection of AqSEJ significantly prolonged the bleeding time in a dose dependent manner. The recorded bleeding time was>10 min (P<0.01) at the concentration of 30 μg against the PBS treated control of 1.48±0.10 min with the IC<sub>50</sub> values 37.5 μg/ml and 47.5 μg/ml respectively. Interestingly, AqSEJ specifically prolonged the clot formation process of only APTT but not PT, revealing the anticoagulation triggered by the extract could be due to its interference in an intrinsic pathway of the blood coagulation cascade. Furthermore, AqSEJ inhibited the agonists such as ADP, epinephrine and collagen induced platelet aggregation of about 66.7%, 39.2% and 37.0% respectively at the concentration of 200 μg.<strong></strong></p><p><strong>Conclusion: </strong>AqSEJ showed anticoagulant and antiplatelet activities. Hence, it may serve as a better alternative for thrombotic disorders.</p></div><div id="__hggasdgjhsagd_once" style="display: none;"> </div>}, number={13}, journal={International Journal of Pharmacy and Pharmaceutical Sciences}, author={Gangaraju, Sowmyashree and Manjappa, Bhagyalakshmi and Subbaiah, Girish Kesturu and Kempaiah, Kemparaju and Shinde, Manohar and Sannaningaiah, Devaraja}, year={2015}, month={Oct.}, pages={187–191} }